The convergence of precision oncology, targeted targeted endocrinology, and novel drug delivery platforms is transforming treatment options across advanced prostate oncology settings. Detailed analysis within the prostate cancer hormone therapy Market report demonstrates that androgen deprivation therapy (ADT) remains the foundational baseline for managing metastatic and locally advanced...